12 Month Price Forecast For PDCO
Distance to PDCO Price Forecasts
PDCO Price Momentum
🤔 Considering Patterson (PDCO)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 12:04 PM UTC
PDCO Analyst Ratings & Price Targets
Based on our analysis of 14 Wall Street analysts, PDCO has a consensus that is neutral. The median price target is $31.35, with forecasts ranging from $24.00 to $31.35. Currently, there are 0 Buy ratings, 12 Hold ratings, and 0 Sell ratings.
With PDCO currently trading at $30.92, the median price forecast suggests a 1.4% upside. The most optimistic forecast comes from Erin Wright at Morgan Stanley, projecting a 1.4% upside, while Jason Bednar at Piper Sandler provides the most conservative target, suggesting a -22.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PDCO Analyst Consensus
PDCO Price Target Range
Latest PDCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PDCO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 17, 2024 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $31.35 |
| Dec 12, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $31.00 |
| Dec 11, 2024 | Leerink Partners | Michael Cherny | Market Perform | Downgrade | $31.35 |
| Dec 6, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $25.00 |
| Dec 6, 2024 | Piper Sandler | Jason Bednar | Neutral | Maintains | $24.00 |
| Dec 5, 2024 | Stifel | Jonathan Block | Hold | Maintains | $24.00 |
| Oct 8, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $22.00 |
| Sep 5, 2024 | UBS | Michael Cherny | Neutral | Maintains | $24.00 |
| Sep 4, 2024 | Baird | Neutral | Maintains | $0.00 | |
| Sep 4, 2024 | B of A Securities | Buy | Maintains | $0.00 | |
| Aug 29, 2024 | B of A Securities | Michael Cherny | Buy | Maintains | $29.00 |
| Aug 29, 2024 | Piper Sandler | Neutral | Maintains | $0.00 | |
| Aug 29, 2024 | Morgan Stanley | Equal-Weight | Maintains | $0.00 | |
| Aug 29, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $28.00 |
| Aug 29, 2024 | JP Morgan | Michael Minchak | Neutral | Maintains | $26.00 |
| Aug 29, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $23.00 |
| Jul 9, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $25.00 |
| Jun 20, 2024 | JP Morgan | Michael Minchak | Neutral | Maintains | $29.00 |
| Jun 20, 2024 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $28.00 |
| May 20, 2024 | B of A Securities | Michael Cherny | Buy | Maintains | $32.00 |
Stocks Similar to Patterson Cos Inc
The following stocks are similar to Patterson based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Patterson Cos Inc (PDCO) Financial Data
Patterson Cos Inc has a market capitalization of $2.73B with a P/E ratio of 18.3x. The company generates $6.53B in trailing twelve-month revenue with a 2.6% profit margin.
Revenue growth is -2.2% quarter-over-quarter, while maintaining an operating margin of +2.1% and return on equity of +16.3%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Patterson Cos Inc (PDCO) Company Overview
About Patterson Cos Inc
Distributes dental and animal health products.
Patterson Companies operates through three segments: Dental, Animal Health, and Corporate. It generates revenue by providing a wide range of products and services including consumable products, dental equipment, practice management software, and a portfolio of veterinary products, along with financing and maintenance services.
Founded in 1877 and headquartered in Saint Paul, Minnesota, the company serves a diverse clientele, including dental professionals, veterinarians, and healthcare institutions across the U.S., U.K., and Canada. The company's history and brand recognition in the dental and animal health sectors position it as a significant player in these markets.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
7,600
CEO
Mr. Donald J. Zurbay
Country
United States
IPO Year
1992
Website
www.pattersoncompanies.comPatterson Cos Inc (PDCO) Latest News & Analysis
Patterson Companies announced the end of its 40-day "go-shop" period for its merger with Patient Square Capital, which will acquire the company for $31.35 per share, totaling about $4.1 billion.
The expiration of the go-shop period signals that Patterson Companies is moving forward with its acquisition, potentially providing certainty in its valuation and impacting stock prices.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders
16 days agoHalper Sadeh LLC is investigating several companies for potential federal securities law violations and breaches of fiduciary duties to shareholders.
Pending investigations by Halper Sadeh LLC could indicate potential legal risks for the companies involved, impacting their stock performance and shareholder value.
Patterson has agreed to be acquired by Patient Square Capital for about $4.1 billion.
Patterson's acquisition at a $4.1 billion valuation signals strong investor confidence, potential for operational synergies, and could impact stock performance and market positioning.
Patient Square Capital will acquire Patterson Companies, Inc. for about $4.1 billion, focusing on its dental and animal health product distribution business.
The $4.1 billion acquisition of Patterson Companies by Patient Square Capital signals confidence in the healthcare sector, potentially influencing stock performance and market sentiment.
Patterson Companies' shares rose 35.9% following a $4.1 billion all-cash buyout by Patient Square Capital. A go-shop period may allow for higher bids.
Patterson Companies' 35.9% stock surge reflects a substantial buyout offer, while the go-shop period hints at potential for higher bids, indicating ongoing investor interest and value.
Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?
1 month agoPatterson Companies stock rose following a $4.1 billion takeover agreement with Patient Square.
The $4.1 billion takeover of Patterson Companies by Patient Square indicates strong market confidence, potentially raising stock value and altering competitive dynamics in the dental sector.
Frequently Asked Questions About PDCO Stock
What is Patterson Cos Inc's (PDCO) stock forecast for 2025?
Based on our analysis of 14 Wall Street analysts, Patterson Cos Inc (PDCO) has a median price target of $31.35. The highest price target is $31.35 and the lowest is $24.00.
Is PDCO stock a good investment in 2025?
According to current analyst ratings, PDCO has 0 Buy ratings, 12 Hold ratings, and 0 Sell ratings. The stock is currently trading at $30.92. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for PDCO stock?
Wall Street analysts predict PDCO stock could reach $31.35 in the next 12 months. This represents a 1.4% increase from the current price of $30.92. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Patterson Cos Inc's business model?
Patterson Companies operates through three segments: Dental, Animal Health, and Corporate. It generates revenue by providing a wide range of products and services including consumable products, dental equipment, practice management software, and a portfolio of veterinary products, along with financing and maintenance services.
What is the highest forecasted price for PDCO Patterson Cos Inc?
The highest price target for PDCO is $31.35 from Erin Wright at Morgan Stanley, which represents a 1.4% increase from the current price of $30.92.
What is the lowest forecasted price for PDCO Patterson Cos Inc?
The lowest price target for PDCO is $24.00 from Jason Bednar at Piper Sandler, which represents a -22.4% decrease from the current price of $30.92.
What is the overall PDCO consensus from analysts for Patterson Cos Inc?
The overall analyst consensus for PDCO is neutral. Out of 14 Wall Street analysts, 0 rate it as Buy, 12 as Hold, and 0 as Sell, with a median price target of $31.35.
How accurate are PDCO stock price projections?
Stock price projections, including those for Patterson Cos Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
